Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Decline in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,276 shares, a decline of 14.2% from the December 31st total of 1,487 shares. Based on an average daily trading volume, of 5,917 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 5,917 shares, the short-interest ratio is currently 0.2 days.

Carl Zeiss Meditec Price Performance

Shares of CZMWY opened at $32.80 on Tuesday. The company’s 50-day simple moving average is $45.79 and its 200-day simple moving average is $49.75. Carl Zeiss Meditec has a 1 year low of $32.59 and a 1 year high of $76.28.

Analysts Set New Price Targets

CZMWY has been the subject of a number of recent analyst reports. The Goldman Sachs Group cut shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold”.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.